PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
1-Year Return
21.39%
This Quarter Return
+9.02%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.15B
AUM Growth
-$149M
(-11%)
Cap. Flow
-$228M
Cap. Flow
% of AUM
-19.74%
Top 10 Holdings %
Top 10 Hldgs %
54.46%
Holding
82
New
17
Increased
13
Reduced
24
Closed
24
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$20.8M |
| 2 |
Natera
NTRA
|
$17.1M |
| 3 |
Cencora
COR
|
$16M |
| 4 |
Masimo
MASI
|
$15.9M |
| 5 |
Akero Therapeutics
AKRO
|
$14.2M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$61.6M |
| 2 |
AbbVie
ABBV
|
$54M |
| 3 |
Elevance Health
ELV
|
$38.4M |
| 4 |
argenx
ARGX
|
$34M |
| 5 |
Universal Health Services
UHS
|
$29.2M |
Sector Composition
| 1 | Healthcare | 96.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$652B
| $209M | 17.79% |
268,023
-5,755
| -2% | -$4.49M |
|
2
Tenet Healthcare
THC
$17.3B
| $87.9M | 7.48% |
499,243
+7,909
| +2% | +$1.39M |
|
3
McKesson
MCK
$85.5B
| $53M | 4.51% |
72,313
-25,185
| -26% | -$18.5M |
|
4
Axsome Therapeutics
AXSM
$6.25B
| $50.4M | 4.29% |
483,105
-73,440
| -13% | -$7.67M |
|
5
Intuitive Surgical
ISRG
$167B
| $48.3M | 4.12% |
88,967
-4,106
| -4% | -$2.23M |
|
6
Penumbra
PEN
$11B
| $42.7M | 3.63% |
166,261
| – | – |
|
7
Ascendis Pharma
ASND
$12.5B
| $38.3M | 3.26% |
221,754
+34,838
| +19% | +$6.01M |
|
8
Soleno Therapeutics
SLNO
$3.71B
| $34.1M | 2.9% |
407,202
-188,004
| -32% | -$15.8M |
|
9
CVS Health
CVS
$93.6B
| $33M | 2.81% |
479,005
+166,700
| +53% | +$11.5M |
|
10
Outset Medical
OM
$249M
| $32M | 2.72% |
1,664,727
-21,000
| -1% | -$403K |
|
11
Danaher
DHR
$143B
| $31.9M | 2.71% |
161,413
+48,938
| +44% | +$9.67M |
|
12
Edwards Lifesciences
EW
$47.5B
| $30.7M | 2.61% |
392,503
+12,549
| +3% | +$981K |
|
13
HCA Healthcare
HCA
$98.5B
| $27.7M | 2.36% |
72,290
-5,174
| -7% | -$1.98M |
|
14
Humana
HUM
$37B
| $26.8M | 2.28% |
109,511
+46,273
| +73% | +$11.3M |
|
15
Molina Healthcare
MOH
$9.47B
| $25.5M | 2.17% |
85,739
+15,651
| +22% | +$4.66M |
|
16
Alnylam Pharmaceuticals
ALNY
$59.2B
| $23.6M | 2% |
72,220
-14,925
| -17% | -$4.87M |
|
17
BridgeBio Pharma
BBIO
$10.2B
| $22.5M | 1.92% |
521,793
-386,342
| -43% | -$16.7M |
|
|
18
Teva Pharmaceuticals
TEVA
$21.7B
| $20.8M | 1.77% |
+1,238,846
| New | +$20.8M |
|
19
Indivior
INDV
$3.12B
| $20M | 1.7% |
1,355,931
+196,098
| +17% | +$2.89M |
|
|
20
Natera
NTRA
$23.1B
| $17.1M | 1.46% |
+101,250
| New | +$17.1M |
|
|
21
Cencora
COR
$56.7B
| $16M | 1.36% |
+53,287
| New | +$16M |
|
|
22
Masimo
MASI
$8B
| $15.9M | 1.35% |
+94,451
| New | +$15.9M |
|
23
Oscar Health
OSCR
$5.02B
| $15.8M | 1.34% |
735,033
-125,788
| -15% | -$2.7M |
|
24
Waters Corp
WAT
$18.2B
| $15M | 1.28% |
43,089
-8,769
| -17% | -$3.06M |
|
|
25
Akero Therapeutics
AKRO
$3.58B
| $14.2M | 1.21% |
+266,167
| New | +$14.2M |
|